The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs

The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs

Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium glucose co-transporter-2 (SGLT-2) inhibitors reduce cardiorenal outcomes. We performed a network meta-analysis to compare the effect on cardiorenal outcomes among GLP-1 RAs, SGLT-2 inhibitors and dipeptidyl peptidase-...

Full description

Bibliographic Details
Main Authors: Dario Giugliano, Miriam Longo, Simona Signoriello, Maria Ida Maiorino, Bruno Solerte, Paolo Chiodini, Katherine Esposito
Format: Article
Language:English
Published: BMC 2022-03-01
Series:Cardiovascular Diabetology
Subjects:
Cardiovascular outcome trials
DPP-4 inhibitors
GLP-1 receptor agonists
SGLT-2 inhibitors
Network meta-analysis
Online Access:https://doi.org/10.1186/s12933-022-01474-z

Similar Items

Similar Items